Evidence map›Paper›PMID 15224182›Full record

ReviewCellular and molecular life sciences : CMLS2004

Keepers at the final gates: regulatory complexes and gating of the proteasome channel.

M Bajorek, M H Glickman

Open access · greenAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Probing the cooperativity ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Protein Expression of Proteasome Subunits in Elderly Patients with Schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
  11. Article
  12. Review
  13. Understanding the mechanism of proteasome 20S core particle gating.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  14. Article
  15. Review
  16. Redox control of 20S proteasome gating.Antioxidants & redox signaling · 2012
    Article
  17. Article
  18. Dependence of proteasome processing rate on substrate unfolding.The Journal of biological chemistry · 2011
    Article
  19. Proteasome activator 200: the heat is on...Molecular & cellular proteomics : MCP · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M BajorekDepartment of Biology and the Institute for Catalysis Science and Technology, Technion -- Israel Institute of Technology, Haifa, Israel.
M H Glickman
Technion – Israel Institute of Technology · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteolytic active sites of the 26S proteasome are sequestered within the central chamber of its 20S catalytic core particle. Access to this chamber is through a narrow channel defined by the outer alpha subunits. Free proteasome 20S core particles are found in an autoinhibited state in which the N-termini of neighboring alpha subunits are anchored by an intricate lattice of interactions blocking access to the channel. Entry of substrates into proteasomes can be enhanced by attachment of activators or regulatory particles. An important part of this activation is channel gating; regulatory particles rearrange the blocking residues to form an open pore and promote substrate entry into the proteolytic chamber. Interestingly, some substrates can open the entrance themselves and thus facilitate their own destruction. In this review, we will discuss the mechanisms proposed for channel gating and the interactions required to maintain stable closed and open conformations.

Indexed as

Amino Acid SequenceCysteine EndopeptidasesHumansMolecular Sequence DataMultienzyme ComplexesProteasome Endopeptidase ComplexProtein Structure, TertiaryStructure-Activity RelationshipCysteine EndopeptidasesMultienzyme ComplexesProteasome Endopeptidase Complex

Identifiers

PMID15224182
PMCPMC11138563
OpenAlexW2414211130

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.